![Matthew During](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Matthew During
No más puestos en curso
Historial de carrera de Matthew During
Antiguos cargos conocidos de Matthew During.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
OVID THERAPEUTICS INC. | Director/Miembro de la Junta | 01/04/2014 | 01/04/2019 |
Director Ejecutivo | 01/04/2014 | 01/03/2015 | |
Director Técnico/Científico/I+D | 01/03/2015 | 01/04/2019 | |
Fundador | 01/04/2014 | 01/04/2019 | |
Presidente | 01/03/2015 | 01/04/2019 | |
Bridgewater Associates LP
![]() Bridgewater Associates LP Investment ManagersFinance Bridgewater Associates LP (Bridgewater) is a registered investment advisor and fund of hedge funds manager headquartered in Westport, Connecticut. The firm was founded by Ray Dalio in 1975. They are a subsidiary of Bridgewater Associates Intermediate Holdings LP, which is owned by Bridgewater Associates Holdings, Inc. Bridgewater provides discretionary investment management services to pooled investment vehicles and single investor funds, and managed account clients. | Corporate Officer/Principal | 01/02/2014 | 01/12/2014 |
The Ohio State University
![]() The Ohio State University Other Consumer ServicesConsumer Services Global Factory, Inc. provides collaborative manufacturing execution systems. The firm's software gather, organize & analyze demand, production & quality data from various sources and monitor key indicators & execute business processes to control, manage & optimize distributed manufacturing operations. The company was founded in 1999 and is headquartered in Santa Clara, CA. | Corporate Officer/Principal | 01/01/2006 | 01/12/2014 |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | Corporate Officer/Principal | - | 01/01/2006 |
Yale University | Corporate Officer/Principal | 01/01/1989 | 01/01/2000 |
NIGHTSTAR THERAPEUTICS PLC | Fundador | 01/01/2014 | - |
Neurologix, Inc. /Old/ | Fundador | - | - |
Merlin Pharma Pvt Ltd. | Fundador | 01/02/1993 | - |
NightstaRx Ltd.
![]() NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Fundador | 01/01/2014 | - |
Formación de Matthew During.
Auckland University | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 6 |
Reino Unido | 3 |
Nueva Zelanda | 2 |
Operativa
Founder | 5 |
Corporate Officer/Principal | 4 |
Director/Board Member | 1 |
Sectorial
Consumer Services | 5 |
Health Technology | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OVID THERAPEUTICS INC. | Health Technology |
Empresas privadas | 5 |
---|---|
Bridgewater Associates LP
![]() Bridgewater Associates LP Investment ManagersFinance Bridgewater Associates LP (Bridgewater) is a registered investment advisor and fund of hedge funds manager headquartered in Westport, Connecticut. The firm was founded by Ray Dalio in 1975. They are a subsidiary of Bridgewater Associates Intermediate Holdings LP, which is owned by Bridgewater Associates Holdings, Inc. Bridgewater provides discretionary investment management services to pooled investment vehicles and single investor funds, and managed account clients. | Finance |
Neurologix, Inc. /Old/ | Commercial Services |
Merlin Pharma Pvt Ltd. | |
NightstaRx Ltd.
![]() NightstaRx Ltd. Medical/Nursing ServicesHealth Services NightstaRx Ltd. develops and commercializes therapies for retinal dystrophies. It offers retinal gene therapy that provides one-time cure for choroideremia (a rare inherited cause of blindness) and other retinal dystrophies. The company was founded by Robert MacLaren, Miguel Seabra, and Matthew During in January 2014 and is headquartered in London, the United Kingdom. | Health Services |
Nightstar Therapeutics Ltd.
![]() Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
- Bolsa de valores
- Insiders
- Matthew During
- Experiencia